Nevada
|
333-72097
|
74-2897368
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
12701
Commonwealth Drive, Suite 9, Fort Myers, Florida
|
33913
|
|
(Address of
principal executive offices)
|
(Zip
code)
|
|
(239)
768-0600
|
||
Registrant’s
telephone number, including area code
|
||
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
|
Exhibit
|
Description
|
Location
|
99.1
|
Settlement
Agreement and Release, dated April 23, 2008, by and among the Company et
al. and Accupath Diagnostics, Inc., d/b/a US Labs
|
Provided
herewith
|
NEOGENOMICS,
INC.
|
|
Date: April
28, 2008
|
By: /s/ Robert
Gasparini
|
Name: Robert
Gasparini
|
|
Its: President
and Principal Executive Officer
|